drugset / Trial / NCT01397370
Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses (MAD) of GLPG0492 given to healthy subjects for 14 days compared to placebo, and to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of GLPG0492 after multiple oral administrations.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG0492 | Small molecule | 5 mg | Oral |
Indications
No indication recorded.